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Abstract
Background: DIALOG+ is a resource-oriented and evidence-based intervention to improve quality of life and
reduce mental distress. While it has been extensively studied in mental health care, there is little evidence for how
to use it in primary care settings for patients with chronic physical conditions. Considering that DIALOG+ is used in
existing routine patient-clinician meetings and is very low cost, it may have the potential to help large numbers of
patients with chronic physical conditions, mental distress and poor quality of life who are treated in primary care.
This is particularly relevant in low- and middle-income countries (LMICs) where resources for specialised services for
such patients are scarce or non-existent.
Methods: An exploratory non-controlled trial will be conducted to primarily assess the feasibility and acceptability
and, secondarily, outcomes of delivering DIALOG+ to patients with chronic physical conditions and poor quality of
life in primary care settings in Bosnia and Herzegovina, Colombia and Uganda. Thirty patients in each country will
receive DIALOG+ up to three times in monthly meetings over a 3-month period. Feasibility will be assessed by
determining the extent to which the intervention is implemented as planned. Experiences will be captured in
interviews and focus groups with care providers and participants to understand acceptability. Quality of life,
symptoms of anxiety and depression, objective social situation and health status will be assessed at baseline and
again after the three-session intervention.
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Discussion: This study will inform our understanding of the extent to which DIALOG+ may be used in the routine
care of patients with chronic physical conditions in different primary care settings. The findings of this exploratory
trial can inform the design of future full randomised controlled trials of DIALOG+ in primary care settings in LMICs.
Trial registration: All studies were registered prospectively (on 02/12/2020 for Uganda and Bosnia and
Herzegovina, and 01/12/2020 for Colombia) within the ISRCTN Registry. ISRCTN17003451 (Bosnia and Herzegovina),
ISRCTN14018729 (Colombia) and ISRCTN50335796 (Uganda). Protocol version and date: v2.0; 28/07/2020 (Bosnia
and Herzegovina), v0.3 02/08/2020 (Colombia) and v1.0, 05/11/2020 (Uganda).
Keywords: Global mental health, Primary care, Psychosocial interventions, Resource-oriented approach, LMICs,
Solution-focused, Quality of life, DIALOG+
Background
Chronic physical diseases, such as diabetes, cardiovascu-
lar disease, HIV/AIDS, and cancer are associated with
increased psychological distress and reduced quality of
life [1–4]. Chronic mental illnesses are often co-morbid
with physical illnesses [5–10] due to shared risk factors,
poorer treatment adherence, and bidirectional causality
[11]. Identifying and treating mental distress in chronic-
ally ill patients has the potential to improve quality of
life and functioning, despite other comorbidities [12].
This calls for the integration of mental and physical care
to address the unmet mental health care needs for pa-
tients with chronic conditions.
Integrating mental and physical healthcare within pri-
mary care has again been highlighted as a priority [13]
and some efforts are underway [14]. However, there are
persistent challenges such as inadequate financing, a lack
of skilled personnel, high patient load, and limited evi-
dence surrounding the design and delivery of interven-
tions that support improved mental health within the
health systems of low- and middle-income countries
(LMICs) [15–19]. In Africa, for example, generally, less
than 1% of health budgets are spent on mental health
[20], and integration of effective interventions in primary
care could significantly improve access, provide patient-
centred care, avoid fragmentation in the health services
and potentially lessen stigma, whilst optimising both
mental and physical health outcomes [21].
DIALOG+ intervention
DIALOG+ is a resource-oriented and evidence-based
intervention, which makes use of existing personal and
social resources to improve the quality of life of patients
with psychological distress by structuring the discussion
that takes place during routine clinical meetings. It en-
courages self-reflection and expression and empowers
patients to take actions to improve their mental health
and social situation [22]. DIALOG+ was developed
based on the quality of life research, concepts of patient-
centred communication, developments in information
technology, and components of solution-focused therapy
to make routine meetings between patients with mental
disorders and healthcare professionals therapeutically ef-
fective (more information at https://dialog.elft.nhs.uk)
[22, 23]. Through a process of patient-centred assess-
ment, clinicians ask patients to rate their satisfaction
with eight life domains and three treatment aspects, on a
seven-point scale ranging from ‘totally dissatisfied’ to ‘to-
tally satisfied’. This is followed by a four-step, solution-
focused approach that guides the clinician to explore the
concerns raised by the patient and possible actions that
can be taken by the patient and others to address these
concerns. Specifically, the four steps outlined in the
manual [24] are (1) Understanding, intended to allow
the clinician and the patient to understand the patient’s
situation by assessing why the rating is the one given
and, for example, not lower, and discussing what is
working; (2) Looking forward, where the patient is en-
couraged to imagine what changes (‘best case scenario’
and ‘smallest improvement’) they would like to see to
their current situation; (3) Exploring options, to see what
practical actions might lead to the desired change, this
includes looking at things that the patient, the clinician
and others can do; and (4) Agreeing on actions, where
the clinician and patient agree on specific actions that
are documented for review at the next session.
DIALOG+ is supported by an app available for a tablet
or smartphone and provides assessment, planning, thera-
peutic intervention and evaluation in one procedure.
The fact that the app is hosted on a tablet means that
the patient is more actively involved in the meeting, and
the tablet can be passed between the patient and the
provider to support discussion. The scores are sum-
marised and can easily be compared on the screen, and,
if this is a subsequent visit, be compared to scores pro-
vided at earlier visits. This gives a rapid overview of the
current problems and strengths in the patient’s life. As
part of the intervention, providers are encouraged to
provide positive feedback domains that are scored high
or, at subsequent visits, any domains that show
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improvement. DIALOG+ requires minimal training and
can be delivered by a broad range of professionals at all
levels of the healthcare system.
In randomised controlled trials in Western Europe,
DIALOG+ has been shown to significantly improve pa-
tient outcomes whilst reducing care costs [22, 23, 25].
However, whilst DIALOG+ has been extensively studied
in mental health care, there is little evidence for how to
use it in primary care settings for patients with chronic
conditions. As DIALOG+ is a low-cost intervention,
which mobilises existing personal and social resources, it
may also be used to support effective community mental
health care within a primary care setting. It could be
used with patients with chronic physical disorders, par-
ticularly if these disorders and associated social prob-
lems impact patients’ quality of life. Given the flexibility
of DIALOG+ and the short training required, it may be
adapted and used for patients with chronic physical ill-
ness and poor quality of life in primary care settings. Ap-
plying an effective evidence-based and resource-oriented
intervention such as DIALOG+ has the potential to im-
prove outcomes for individuals with chronic conditions
and make efficient use of limited resources in primary
healthcare in LMICs. Within this setting, DIALOG+
may help to develop service capacity and improve clin-
ical and social outcomes. This study will inform our un-
derstanding of the extent to which DIALOG+ may be
used in the routine care of patients with chronic physical
conditions in different primary care settings in LMICs.
Aims and objectives
The primary aim of the exploratory study is to assess the
feasibility and acceptability of using DIALOG+ for pa-
tients with chronic physical illness and poor quality of
life in primary care settings in three LMICs. A secondary
aim is to assess changes in key outcomes.
Methods
Design
This work developed from The NIHR Global Health Re-
search Group on Developing Psycho-social Interventions
in Low- and Middle-Income Countries (GLOBE), a
multi-disciplinary collaboration between Queen Mary
University of London, East London NHS Foundation
Trust, and partners in Bosnia and Herzegovina (Clinical
Centre, University of Sarajevo), Colombia (Javeriana
University) and Uganda (Makerere University, College of
Health Sciences) [26]. As part of this collaboration,
GLOBE specifically set out to test resource-orientated
approaches for addressing mental health globally. Cen-
tral to the work completed by GLOBE were three rando-
mised controlled trials of DIALOG+. Following the
successful recruitment and implementation of DIA-
LOG+ within services for people with serious mental
illness, potential new and extension projects were dis-
cussed. Positive clinician and patient feedback and pre-
liminary quantitative findings suggested the intervention
improved quality of life, reduced psychiatric symptoms
and increased empowerment. The team identified the
needs of individuals with co-morbid long-term physical
and mental health conditions, often treated within pri-
mary care, as an urgent and common priority in all three
countries.
DIALOG+ will be applied in primary care settings in
an exploratory non-controlled trial. The evaluation will
use mixed methods, with outcomes measured at baseline
and the end of the intervention period. Implementation
processes will be informed by a stakeholder consultation
based on actual experience of implementing the inter-
vention in the previous DIALOG+ GLOBE trials [26].
The results will provide insight into refining the manua-
lised training process and implementing the intervention
across healthcare settings. The first stages of the study
may involve minor modifications to DIALOG+ to ensure
that it is useable in the primary care context in the par-
ticipating LMICs. Potential adaptations may include sug-
gested modifications to item wording and training
material, especially around when and who delivers each
component of the intervention.
A core research protocol was developed to ensure
comparable implementation across countries and core
outcomes, but there was some flexibility to adapt the
protocol to be suitable for local implementation. There-
fore, there are some small differences with regard to
some of the measures and inclusion criteria. Addition-
ally, the local teams identified primary care clinic popu-
lations that they were able to integrate the DIALOG+
work with. This is reported here with reference to the
Spirit Guidelines [27] and with consideration of guide-
lines on the reporting of pilot and feasibility studies [28].
Patients and procedures
We will target chronic non-communicable disorders
such as diabetes, cardiovascular disease, chronic ob-
structive pulmonary disease and hypertension, as these
conditions negatively impact on quality of life and are
highly comorbid with mental distress [29]. Adult pa-
tients (18–65 years in Bosnia and Herzegovina and
Colombia, 18+ in Uganda where the selected clinic
population (diabetes and hypertension) was anticipated
to be older) with at least one chronic condition and poor
quality of life (< 5 on the Manchester Short Assessment
of Quality of Life [MANSA], < 5.5 in Colombia where in
our previous work, participants with mental illness tend
to score slightly higher on quality of life). Additionally,
participants must exhibit the capacity to provide in-
formed consent, speak the local language, live within a
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20-km radius of the clinic and have been attending the
primary care clinic for at least 6 months.
Participants who do not meet these criteria or who are
unwilling or unable to provide informed consent will not
be eligible for participation.
For clinicians, they must be qualified health profes-
sionals currently working in the relevant primary care fa-
cilities with no plans to leave their post within 4
months.
Consent
Individuals who respond to the study information with
interest will be contacted and invited by phone or letter
to attend a face-to-face meeting with a researcher. Re-
searchers will discuss the study with interested individ-
uals and answer any questions or concerns that are
raised. At this stage, contact details will be confirmed,
and availability ascertained for attendance of interven-
tion sessions, interviews or appointments.
Prior to any data collection, all participants, including
clinicians, will be asked to provide informed consent by
signing and dating an informed consent form. Two cop-
ies of the written consent form will be signed by the par-
ticipant and a member of the research team in order to
proceed with study participation. The participant will
keep one copy of the informed consent form and the re-
search team will keep the other, storing it in a locked fil-
ing cabinet.
Specific procedures will be implemented in each coun-
try and reviewed and approved by the local ethics com-
mittee to determine how to facilitate and document
consent for all participants, including those with low
literacy.
All researchers will receive Good Clinical Practice
training by members of the UK-based research team, or
senior members of the local research team, or through
online/official courses. The researchers will assess each
patient's level of understanding during the recruitment
and consent process, alongside discussion with the pa-
tient’s clinician where necessary. If any doubts about
their capacity emerge during the recruitment process, or
capacity to consent appears to change during their par-
ticipation in the study, their capacity to consent will be
re-evaluated before continuing with study participation.
Sample size
We plan for a sample size of at least 30 participants en-
rolled per country. Central limit theory suggests 30 as a
minimum sample size to enable meaningful parameter
estimates in an exploratory study [30]. We anticipate
that each of around five clinicians enrolled in each coun-
try will deliver the intervention to approximately six
participants.
Time periods
Once enrolled, patients will receive DIALOG+ at their
routine primary care appointments, about once per
month. Sessions will be delivered by the healthcare
worker supported by an app on a tablet computer. The
intervention period will be approximately three months,
during which patients will attend up to three DIALOG+
sessions.
Data collection with all participants will take place
at baseline and following the three-session interven-
tion period. At baseline, the researchers will collect
socio-demographic information from all participants,
which, for patient participants, will include clinical
characteristics.
At the conclusion of the intervention period, all clini-
cians and a subset of patients will be invited to attend an
interview. The remaining patients will be asked to take
part in focus group discussions. These discussions will
follow a structured guide, and be conducted by trained
and experienced researchers. Specific consent will be ob-
tained to audio-record interviews and focus group dis-
cussions, which will be transcribed verbatim for analysis.
These data will be used to capture the experiences of re-
ceiving or delivering the intervention in primary care
and be used to assess the acceptability of the DIALOG+
in this context.
In addition to the research data collection, the re-
search and clinical support staff will keep a record of
their intervention sessions. These reports will include
the date, duration of interventions and the topic of dis-
cussion. This information is also captured within the DI-
ALOG+ app and can be retrieved by the research staff.
The aim is to audio record at least one session per pa-
tient, which will be scored for adherence to the interven-
tion, using the DIALOG+ Adherence Scale. Specific
consent will be sought for these recordings. These data
will be used to assess the feasibility of implementing the
intervention in this context.
Withdrawal
During the consent process, researchers will ensure that
participants are aware of their right to decline participa-
tion at any stage of the research and that withdrawing
participation will not affect their treatment or rights.
Participants who withdraw will be able to ask for their
data to be removed from the study, providing this occurs
within the intervention period.
If patients withdraw from the intervention, then the
research team will ask permission to contact them to
take part in the follow-up assessment and post-
intervention qualitative interview in order to capture
valuable information regarding reasons for withdrawal,
which might be associated with the intervention. This
will be explained to patients during the consent process.
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The research team will respect the decision of patients
who do not wish to be contacted for the follow-up as-
sessment and post-intervention interview.
If a participant wishes to withdraw from the study, re-
searchers will record the date of withdrawal and rea-
son(s) for withdrawal if provided.
Measures
Capacity to consent at screening:
In Uganda, all participants will be assessed with the Uni-
versity of California, San Diego Brief Assessment of Cap-
acity to Consent (UBACC); used to identify subjects
with questionable capacity to consent to the specific re-
search project. It has good internal consistency, inter-
rater reliability, concurrent validity, high sensitivity, and
acceptable specificity. It typically takes less than five mi-
nutes to administer and is easy to use and reliably score
[31]. Participants will need to reach an adequate stand-
ard within three administrations of this instrument.
In Colombia and Bosnia and Herzegovina, researchers
will implement an adapted capacity to consent checklist,
based on that published by the British Psychological So-
ciety, for those participants who it is felt may lack the
capacity to consent [32].
In all countries, responses to these measures will be
used to structure discussions with participants to at-
tempt to allow them to reach a standard required for
enrolment.
Recruitment and retention rates:
Process measures will be used to assess the feasibility of
the intervention in this context. We will assess patient
and clinician recruitment and attrition (reasons for re-
fusal and loss to follow-up), frequency and duration of
sessions. Feasibility criteria include at least 75% recruit-
ment of the anticipated participants, coupled with at
least 75% retention [28]. An additional feasibility criter-
ion will be an average of at least two out of the three
planned sessions completed.
Key outcome measures
For all patients and clinicians: socio-demographic infor-
mation will be collected at baseline.
The impact of the intervention on key outcomes will
be evaluated by assessing changes in the following mea-
sures, assessed at baseline and at the end of the interven-
tion period:
1. Quality of life will be measured using the
Manchester Short Assessment of Quality of life
(MANSA), a 16-item scale which assesses quality of
life across different life domains [33].
2. Patient Health Questionnaire (PHQ-9 in Uganda
and Bosnia and Herzegovina, PHQ-8 in Colombia
(where the research team has more experience with
this version of the PHQ and the scores are compar-
able [34]) is a brief depression scale with good sen-
sitivity and specificity, and consists of the criteria
upon which the diagnosis of DSM-IV depressive
disorders is based. The scale will be scored as the
PHQ-8 for the pooled analysis across countries.
3. Generalised Anxiety Disorder Assessment (GAD-7);
has been used in primary care and has good
validity, and reliability [35].
4. The Objective Social Outcomes Index (SIX)
summarises objective indicators of social outcomes
in mental health and has been shown to capture
changes over time [36].
5. Physical Health Symptoms was designed for use in
clinical practice and research, health policy
evaluations, and general population surveys [37, 38]
(the SF-36 will be used in Uganda and Bosnia and
Herzegovina, and the SF-12 in Colombia which has
been validated for use in Latin America [39, 40] and
is shorter to administer).
Participant experience
To assess acceptability, qualitative interviews and focus
groups will be conducted to capture patient and clinician
experiences of receiving and delivering the intervention,
suggested adaptations to training material and supervi-
sion, barriers and facilitators of attendance and delivery,
and the impact of the intervention on routine meetings.
Settings
This study will be conducted in primary care settings in
each country. These are arranged and managed differ-
ently in each country, and so will be described briefly
here.
Bosnia and Herzegovina
Health care is organised differently in the two entities of
Bosnia and Herzegovina (BiH) – Federation of Bosnia
and Herzegovina and Republic of Srpska. In the Feder-
ation of Bosnia and Herzegovina, where our study will
take place, organisation of health care is delivered
through the ten cantons with ten respective cantonal
health ministries and a Federal ministry of health which
has a guidance role [41, 42]. Continuity of care is a key
characteristic of primary health care.
The Public Institution Health Centre of Sarajevo Can-
ton is the largest institution in BiH providing primary
health care [43]. The institution has nine community
health centres, one in each municipality. Primary health
care services involve family medicine and primary men-
tal health care in the Community Mental Health
Centres. Some secondary health care services are also
available in this institution – internal medicine,
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neurology, ophthalmology, ear nose and throat, and den-
tal medicine. The aim of primary health care is to make
health services accessible and available for all the citi-
zens, so the outpatient clinics are placed in the local
communities.
Although Bosnia and Herzegovina is one of the most
vulnerable societies in the region, it has made significant
progress in the area of mental health care reform, which
was launched in 1996 focusing on community-based
mental health. BiH is the only country in South-East
Europe that has set up a network of 74 community-
based mental health centres which provide services to
3.8 million residents [44]. The centres employ multi-
disciplinary teams comprising psychiatrists, psycholo-
gists, social workers and medical nurses; some centres,
however, also employ occupational therapists, defectolo-
gists, speech therapists, somatotherapists, and child
psychiatrists. These processes aim to build an effective,
efficient and high-quality mental health service focused
on the user needs, accessible to as many people as
possible in the context of the integrated system of ser-
vice delivery. The mental health care system needs to
protect human rights, ensure gender equality and effi-
ciently respond to the diverse needs of the population,
especially of the most vulnerable groups.
This study will recruit patients from the Public Institu-
tion Health Care Centre of Sarajevo. Clinicians who will
deliver the interventions are physicians who work at the
primary health care centre of Sarajevo. The intervention,
patient assessments, interviews and physician training
will take place in the offices of primary health care cen-
tres which provide privacy and confidentiality.
Colombia
In Colombia, the new model of care emphasises the role
of primary care in the national public health strategy.
The policy ‘PAIS’ (Plan de Atención Integral en Salud,
or comprehensive health care policy) appears in this new
model, which seeks to provide an integrated model of
healthcare, in such a way that the entire territory has
timely, effective and high-quality access, based on a
health promotion and prevention strategy. This model is
called MIAS (Modelo Integral de Atención en Salud, or
comprehensive health care model) and proposes an
evaluation of the health needs of a given territory (city,
municipality, state) in such a way that, with the health
insurance entities either EPS (Entidad Promotora de
Salud, or Health Promoting Entity) or IPS (Institución
Prestadora de Servicios, or Service Provider Institution),
strategies are developed that address these needs. For
this, the model proposes the development of compre-
hensive health care routes (RIAS, Red Integral de Aten-
ción en Salud). The first access route is provided by
primary health care, which seeks to guarantee timely
access to medical care. However, another function is to
establish the specific care route by risk groups, to guar-
antee appropriate care. Within this, there are 16 risk
groups, among which are those with mental health prob-
lems, violence-related issues and problems related to
drug abuse. However, the capability of the primary care
level to deal with chronic conditions has been limited.
Increasing the capacity of primary care services to man-
age chronic conditions in an integrated way is a priority
for the system. Comorbidity is managed in primary care
as there is a lack of specialists within the healthcare sys-
tem [45].
In Colombia, the study will be conducted in Bogotá
and the clinicians and the patients will be recruited from
Javesalud Institución Prestadora de Servicios (IPS, Ser-
vice Provider Institution). The intervention and assess-
ments sessions and interviews will take place in private
rooms within clinics or other participating institutions.
However, with COVID-19 restrictions in place (see sec-
tion later) most sessions with patients are likely to be
virtual (an attempt will be made to have the first DIA-
LOG+ contact in person if possible), with care providers
at the clinic providing most contacts by video-call or
telephone.
Uganda
Primary health care in Uganda is provided by both the
public and private sectors with the public sector contrib-
uting approximately 60% [46]. The public sector has a
referral system with the national referral hospitals as the
final points of health services; however, this is often
exploited due to a lack of a clear gatekeeper role [47].
Primary health care should be provided by the units in
the Health Sub-district but this is not the norm [46].
Communities use the nearest health facility as their pri-
mary health care service and so those living near the re-
ferral hospitals use them as their primary care services
without following the intended referral pathway [47]. In
Uganda, this study will be carried out at the medical
outpatient clinics of Masaka regional referral hospital
and Mityana district hospital. The outpatient clinics are
for chronic illnesses like diabetes and hypertension and
are run by health workers that include doctors, clinical
officers and senior nurses.
SARS-CoV-2 (COVID-19) modifications
The COVID-19 pandemic has affected the three in-
volved countries quite differently, although restrictions
and social distancing have impacted all preparatory and
planned activities. In the main studies [26], some follow-
up and intervention sessions could not take place in per-
son due to pandemic restrictions and social distancing.
We have learned from these experiences, and the team
is prepared to provide remote or socially distanced
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DIALOG+ and assessment visits as necessitated by in-
country requirements. Initial plans are for most interac-
tions to be conducted remotely in Colombia. The first
DIALOG+ session will be delivered to patients face-
to-face, if possible, whilst recruitment and follow up
visits and assessments will be conducted via telephone
or video conferencing. In Uganda and Bosnia and
Herzegovina face-to-face contact is still possible and
visits are subject to social distancing and infection
control procedures, although the situation in Bosnia
and Herzegovina is more uncertain due to increasing
case rates. All sites have protocols and plans in place
to implement appropriate social distancing or remote
delivery to respond to local requirements and regula-
tions which may change at any time. We anticipate
this will allow us to refine procedures implemented in
the initial studies, whilst also being able to reflect on
whether remote delivery of DIALOG+ is feasible and
acceptable and what impact this may have on the
outcomes. All modifications to DIALOG+ delivery
and assessment visits are carefully documented for
reporting and analysis purposes. Modifications to pa-
tient contact are subject to ethics committee review
and approval.
Data management and analysis
All data will be collected on paper case report forms and
pseudonymised data will be entered onto a secure shared
electronic database, REDCap, hosted centrally at QMUL.
Local coordinators and the UK team will provide regular
monitoring to ensure accurate data collection and entry.
All patient-identifiable data will be stored separately at
the local research site in a locked and access-controlled
filing system.
Data analysis will be discussed and agreed with the
local research teams and formulated into a statistical
analysis plan. The study’s international Advisory Group
will be consulted if required. The local research team
will take a leading role in the management and analysis
of data. Data analysis will not be conducted until a stat-
istical analysis plan has been agreed. Once signed off,
the plans will be available on request.
The studies will first be analysed separately, where the
mean outcome scores will be compared before and after
the intervention. We will also combine the fully anon-
ymised datasets from the three countries. This will make
it possible to compare findings and experiences and to
learn from commonalities and differences. The director
of the Group will have access to the final complete data-
set. Reasonable requests for the anonymised quantitative
data, formalised through a data sharing agreement, will
be possible one year after the study has concluded to
allow for all primary publication activities to be
completed.
Quantitative data analysis
The number of screened participants, eligible partici-
pants and of those who refused participation or were not
approached will be recorded. The analysis will assess the
number of intervention sessions received by patients and
will collect data on drop-out (including reasons for
drop-out if available) from treatment, which will inform
the assessment of acceptability and feasibility of the in-
terventions. The life domains and treatment aspects se-
lected for discussion in the DIALOG+ sessions will be
tabulated.
Descriptive statistics will be reported for socio-
demographic data for all participants. To assess for any
changes in outcomes for patients using DIALOG+, mean
and standard deviations over two time points (baseline
and after the intervention period) will be calculated, with
significance tests.
Qualitative data analysis
Qualitative data will be analysed using qualitative con-
tent analysis [48] and will be conducted using NVivo
qualitative analysis software. All interviews will be
audio-recorded and transcribed verbatim for analysis. A
researcher will remove all identifying information from
the transcripts, including any references to patients, cli-
nicians or local services.
A mixed deductive and inductive approach will be
used to code the qualitative data. This will be based both
on a coding framework developed alongside the inter-
view topic guides to provide insights regarding the expe-
riences of delivering and receiving the interviews,
suggested adaptations to training material, barriers and
facilitators of attendance and delivery, and the impact of
DIALOG+ on routine meetings and care, as well as
allowing for new codes to emerge inductively from the
data.
Dissemination
The researchers intend to publish the quantitative and
qualitative findings from this study by October 2022.
Dissemination will target different stakeholders, in-
cluding mental health service commissioners and pol-
icymakers, clinicians, patients, carers, academics and
the general public. This study is part of a research
group which also aims to build sustainable research
capacity. The dissemination plan therefore aims to in-
form research, policy and practice. The researchers
plan to disseminate findings across Uganda, Bosnia
and Herzegovina and Colombia, as well as regionally
and globally. Dissemination will include peer-reviewed
academic publications by researchers, conference pre-
sentations, and using platforms like Twitter and the
Group and local research team websites.
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Discussion
People with chronic physical illness in primary care fre-
quently experience comorbid psychological distress, and
associated poor quality of life remains a key concern.
However, there is limited evidence regarding the design
and delivery of interventions for this population, espe-
cially in LMICs. DIALOG+ is used in existing routine
patient-clinician meetings and is very low cost, and it
may have the potential to help large numbers of patients
with chronic physical conditions, mental distress and
poor quality of life who are treated in primary care. This
is particularly relevant in LMICs where resources for
specialised services for such patients are scarce or non-
existent. There is considerable evidence that DIALOG+
improves quality of life in patients with mental disorders,
but also emerging evidence that it improves anxiety and
depression and quality of life in patients with mental dis-
tress (Saleem S, Baig A, Sajun S, Bird VJ, Priebe S, Pasha
A: A mixed methods exploration of structured patient-
clinician communication with a solution focused ap-
proach (DIALOG+) in community treatment of patients
with common mental health disorders in Pakistan, un-
published). This present study will build on this evidence
base and assess the feasibility, experiences and outcomes
of delivering the intervention in primary care settings in
LMICs. Feasibility will be assessed by determining the
extent to which the intervention is implemented as
planned. Acceptability will be assessed through experi-
ences as captured in interviews and focus groups with
care providers and participants. Improvements from
baseline to the end of the intervention period will be
used to assess the impact of the intervention in this con-
text. This trial will inform our understanding of the ex-
tent to which DIALOG+ needs to be flexibly adapted for
new settings, or if the approach can be standardised
across a range of patient groups and settings.
Task sharing and integrating mental health into pri-
mary care have been highlighted as crucial steps to-
wards closing the mental health treatment gap. As a
manualised, app-assisted intervention, DIALOG+
could be easily adapted for delivery by non-mental
health professionals. This study will provide valuable
insights into the potential for task-sharing and deliv-
ery in multiple settings. By conducting comparable
trials in three health systems, including a mix of
LMICs in three continents, our findings could have
applicability across multiple settings.
Evidence from high-income settings suggests DIALOG+
is a cost-saving intervention for people with mental disor-
ders. Research in high-income countries estimates that the
top 5% of chronic patients utilise over 50% of all health-
care resources [49]. In low-resource settings, this interven-
tion provides an opportunity to leverage existing routine
meetings in primary care to deliver a cost-effective or
cost-saving intervention. There is the potential to expand
into other primary care settings or other meetings be-
tween care providers and patients with poor quality of life.
We anticipate that anyone who has routine meetings with
patients in primary care could potentially incorporate DI-
ALOG+ into those meetings, providing structure and a
way to improve patient quality of life and mental distress.
We anticipate this would include, but not be limited to,
doctors, nurses, counsellors, lay counsellors and associated
community healthcare workers, and pharmacists. Process
measures will help to better understand the staffing and
resources required for wider implementation.
Conclusion
The factors that lead to lowered quality of life are likely
to be numerous and complex, and so a holistic interven-
tion that concurrently addresses numerous aspects relat-
ing to patient quality of life, like DIALOG+, is likely to
be more efficient and effective, rather than an interven-
tion which focuses on specific aspects of their treatment
or disease. The findings of this exploratory trial can in-
form the design of future full randomised controlled tri-
als on DIALOG+ in primary care settings in LMICs.
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